VijayGarudBhojMD

Pathology • Philadelphia, PA

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Bhoj is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhoj's full profile

Already have an account?

Office
3400 Spruce St
Philadelphia, PA 19104
Phone+1 215-662-4829

Education & Training

University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine, 2013 - 2014
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2010 - 2013
University of Texas Southwestern Medical SchoolClass of 2010

Certifications & Licensure

PA State Medical License 2010 - 2024
American Board of Pathology Pathology - Clinical
American Board of Pathology Blood Banking/Transfusion Medicine

Publications & Presentations

PubMed

Cars pick up another passenger: Organ transplantation.
Georgia F Papadaki, Yang Li, Dimitri S Monos, Vijay G Bhoj
Human Immunology. 2024-11-25
Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab.
Kyumin Lee, Julia Q Chau, Yani B Suber, Anna R Sternberg, Allyson M Pishko
Blood. 2024-09-12
1 citations
Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis.
Ethan A Mack, Meaghan C Dougher, Ashley M Ginda, Caitlin Cahill, Melissa Murter
Blood. 2024-03-14

Journal Articles

Induction of Resistance to Chimeric Antigen Receptor T Cell Therapy by Transduction of a Single Leukemic B Cell
Vijay G Bhoj, David M Barrett, Carl H June, Stephan A Grupp, David E Ambrose, Saar I Gill, Marco Ruella, Bruce L Levine, Shannon L Maude, Nature

Lectures

Optimized FVIII-Domain-Based Chimeric Antigen Receptors to Specifically Target FVIII Inhibitor-Producing B Cells in Hemophilia a
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Looking Back, Looking Forward: Penn’s CAR-T Program Continues Path of ProgressAugust 28th, 2024
Penn Medicine Awarded $14 Million NIH Grant to Apply CAR T Immunotherapies to Match More Patients in Need of Kidney TransplantsDecember 27th, 2021
Burroughs Wellcome Fund Awards $1.9 Million in Grants to Three Penn ResearchersJune 15th, 2017